4 min read

How many FDA-approved drugs are there?

FDA data contain 26,715 active prescription and OTC drug product records as of July 2026. These represent 13,961 applications, 4,539 drug names, and 2,329 distinct nonblank ingredient entries.

Matic Broz

Computational chemist

The FDA's standard public answer is that there are more than 20,000 approved prescription drug products in the United States.

A count of the agency's downloadable data gives a more precise snapshot. As of July 17, 2026, Drugs@FDA contained 26,715 product records with active prescription or over-the-counter status. Those records represented 13,961 applications, 4,539 drug names, and 2,329 distinct nonblank ingredient entries.

How many FDA-approved drugs are there?

There are 26,715 active prescription and over-the-counter drug product records in the July 2026 Drugs@FDA data, including 25,918 prescription products and 797 OTC products.[1]

The FDA itself uses the rounded figure of more than 20,000 approved prescription drug products.[2] Our count is higher because it includes OTC products and treats each application product number as a separate record. A drug sold in several strengths or dosage forms can therefore appear more than once.

What is countedJuly 2026 count
Active prescription product records25,918
Active OTC product records797
Active prescription and OTC product records26,715
Applications with at least one active product13,961
Distinct drug names among active products4,539
Distinct nonblank ingredient entries among active products2,329
FDA-approved drug counts by counting level, from 26,715 active product records to 2,329 distinct nonblank ingredient entries

ProteinIQ calculated these figures from the Products, MarketingStatus, and MarketingStatus_Lookup tables in the Drugs@FDA download dated July 17, 2026. “Active” means that a product had a marketing status of Prescription or Over-the-counter.[1]

Drugs@FDA covers most approved human prescription, generic, therapeutic biological, and OTC drug products from 1939 onward. The FDA updates it each weekday.[1][3]

Why is there no single count of unique FDA-approved drugs?

There is no single count because a drug product, application, brand name, active-ingredient entry, and unique active molecule are different units.

The 26,715 figure counts products. One ingredient can appear under several brands, manufacturers, strengths, routes, and dosage forms. A combination product can contain several ingredients, while one application can cover several products.

Even the 2,329 ingredient-entry count is not a clean total of unique molecules. The Drugs@FDA field contains exact names, including salts, complexes, combination entries, and biologic naming suffixes. Earlier work on approved-drug collections found that regulatory sources can use several names for the same active pharmaceutical ingredient, such as acetaminophen and paracetamol or different salt forms of one drug.[4]

This is also why third-party databases report different totals. Some combine approvals from several countries, merge synonymous ingredients, include withdrawn medicines, or count a combination as one drug. A credible number must name both the database and the unit being counted.

How many new drugs does the FDA approve each year?

The FDA approved 46 novel drugs in 2025, while the annual average from 2016 through 2025 was about 47.[5][6]

A novel drug is one never previously approved or marketed in the United States. This count excludes most generic approvals and many approvals for new uses, doses, formulations, or patient populations of existing drugs.

Annual novel approvals therefore add only a small number to the much larger product total. Each new active ingredient can later support several branded products, strengths, dosage forms, and generic versions. Reaching that first approval commonly takes 10 to 15 years and about USD 700 million to USD 1.3 billion after failed programs and capital costs are included.

Does FDA approval mean a drug is still sold?

No. Drugs@FDA keeps historical records, and its July 2026 download contains 23,389 discontinued product records alongside the 26,715 active prescription and OTC records.[1]

It also contains 1,439 records with tentative approval. A tentative generic approval means the application is ready for approval but cannot yet receive final approval because of patent protection or exclusivity. It does not allow the applicant to market the product.[8]

“Discontinued” does not mean that every product was removed for safety reasons. The FDA notes that products may be listed as discontinued because they were never marketed, stopped being marketed, or had approval withdrawn for reasons other than safety or effectiveness.[7]

The distinction matters in research. Approved-drug libraries used for repurposing or molecular docking can include products that are no longer sold, so studies should state whether they include discontinued drugs, ingredient variants, and combination products.

ProteinIQ. "How many FDA-approved drugs are there?" Published July 23, 2026. Accessed [your access date]. https://proteiniq.io/guides/how-many-fda-approved-drugs

Sources
  1. Drugs@FDA Data Files U.S. Food and Drug Administration · July 23, 2026. https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files
  2. FDA at a Glance U.S. Food and Drug Administration · July 23, 2026. https://www.fda.gov/media/143704/download
  3. About Drugs@FDA U.S. Food and Drug Administration · July 23, 2026. https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda
  4. The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics Science Translational Medicine · 2011. https://pmc.ncbi.nlm.nih.gov/articles/PMC3098042/
  5. Novel Drug Approvals for 2025 U.S. Food and Drug Administration · July 23, 2026. https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025
  6. Advancing Health Through Innovation: New Drug Therapy Approvals 2025 U.S. Food and Drug Administration · 2026. https://www.fda.gov/media/190705/download
  7. Additions/Deletions for Prescription and OTC Drug Product Lists U.S. Food and Drug Administration · July 23, 2026. https://www.fda.gov/drugs/drug-approvals-and-databases/additionsdeletions-prescription-and-otc-drug-product-lists
  8. Drugs@FDA Glossary of Terms U.S. Food and Drug Administration · July 23, 2026. https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-glossary-terms
Matic Broz

Founder and computational chemist, ProteinIQ

Dr. Matic Broz is the founder of ProteinIQ and a computational chemist. He completed a PhD focused on protein structure, molecular dynamics, and neural networks, and writes about structural biology and scientific software.